We provide a complementary package of outcomes research services geared specifically to infectious disease research
Our services include: transmission modelling, studies of disease epidemiology, and burden of illness. We use a variety of methods including modelling, prospective data collection, statistical analysis, systematic review, patient- and clinician-reported outcomes, and health technology assessment.
ICON is a market leader in infectious disease transmission modelling, and has integrated these into economic models to assess the effectiveness of therapeutic strategies for treating or preventing infectious disease. Our infectious disease modelling comes together with other services in Epidemiology, Health Economics and Patient-reported Outcomes to provide a full range of infectious disease services.
These areas perfectly complement each other and are supported by thorough understanding of the underlying biological principles of infectious disease transmission. Our ability to integrate and innovate while maintaining rigorous standards sets us apart from other consultancies.
Our experience ensures we understand the standards required for submission of single or multiple technology assessments to NICE, the UK Joint Committee on Vaccination and Immunisation (JCVI), the European Medicines Agency (EMA), the FDA or Health Canada.
Our team has experience of evaluating a range of technologies, including vaccines, antibiotics, anti-virals and anti-infectives using a diverse variety of analyses to explore cost-effectiveness, budget impact, pricing and the production of core value documents. While some of these techniques may be unfamiliar to clients, we are able to deliver results in an easy to use, clear and comprehensible format that addresses the objectives set by our customers.